GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn Posted on April 13, 2022July 10, 2023 by fraziermwd
Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis Posted on January 25, 2022July 10, 2023 by fraziermwd